SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.15-0.7%Jan 20 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dlc who wrote (9324)3/23/1999 1:18:00 AM
From: aknahow  Read Replies (2) of 17367
 
Mortality in the two arms will be announced in relatively short time after the trial ends.

That, is an expectation, will it come true I don't know. People will draw there own conclusions. Murphy, based on an erroneous premiss, thinks there may be zero deaths in the treatment arm. His facts regarding the number in the trial are wrong. But he points out that if there is a dramatic low death rate in those treated you have real news that will make the T.V.

The delay in the trials end is probably bullish as many of us have posted and Murphy points out. He also says as we did that the market understands what the delay means.

Also this drug will probably be fast tracked if successful.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext